Related Experiment Video

Updated: Aug 13, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Staphylococcus aureus pneumonia: emergence of MRSA in the community

Suzanne F Bradley1

  • 1Department of Internal Medicine, Division of Infectious Diseases, University of Michigan Medical School, Ann Arbor, Michigan, USA. sbradley@umich.edu

Seminars in Respiratory and Critical Care Medicine
|January 3, 2006
PubMed

Insights

Severe staphylococcal pneumonia is emerging in young, healthy individuals. This trend is linked to community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) strains carrying potent toxins, necessitating early diagnosis and intervention.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pulmonology

Background:

  • Staphylococcal pneumonia presentation is evolving.
  • Severe necrotizing infections and high mortality are observed in healthy young individuals without traditional risk factors.
  • This clinical picture resembles historical outbreaks of postinfluenzal staphylococcal pneumonia.

Purpose of the Study:

  • To highlight the changing clinical presentation of staphylococcal pneumonia.
  • To identify the characteristics of emerging virulent strains.
  • To emphasize the importance of early recognition and treatment of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA).

Main Methods:

  • Clinical case review and microbiological analysis of staphylococcal strains.
  • Identification of virulence factors, including Panton-Valentine leukocidin.
  • Epidemiological assessment of strain characteristics and resistance patterns.

Main Results:

  • Emerging staphylococcal pneumonia cases predominantly involve community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA).
  • Many strains harbor toxins, such as Panton-Valentine leukocidin, contributing to severe necrotizing infections.
  • These virulent CA-MRSA strains are often not healthcare-associated and show potential for widespread dissemination.

Conclusions:

  • The rise of virulent CA-MRSA strains necessitates prompt clinical recognition and microbiological confirmation.
  • Effective treatment and infection control strategies are crucial to manage this evolving public health threat.
  • Understanding the genetic elements conferring resistance and virulence is key to combating staphylococcal pneumonia outbreaks.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...